Burning Rock Biotech Limited stock is down -1.16% since 30 days ago. The next earnings date is Mar 26, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 February’s closed higher than January.
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. Its products include OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass IO, the corresponding test for liquid biopsy samples. The company also offers LungCore for lung cancer, ProstrateCore for prostrate cancer, BreastCore for breast cancer, LymphPlasma for lymphomas, and ThyroCare for thyroid cancer.
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!